Cataract News and Research

Latest Cataract News and Research

First Edition: May 21, 2013

Today's headlines include stories examining how the approaching implementation of some health law provisions is highlighting key policy questions.

21 May 2013

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

InSite Vision Incorporated today announced that patient enrollment has begun in the confirmatory Phase 3 clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain after cataract surgery.

10 May 2013

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Omeros Corporation today reported analyses of Phase 2 and Phase 3 clinical data showing the favorable impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement.

25 Apr 2013

Sony Electronics installs medical-grade 3D imaging solution for ophthalmic surgery

Sony Electronics, a leader in providing innovative imaging solutions for microsurgery, announces the first east and west coast installations of its end-to-end 3D imaging solution for ophthalmic surgery.

12 Apr 2013

FDA approves PROLENSA for treatment of inflammation, pain after cataract surgery

Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration has approved the company's New Drug Application for PROLENSA (bromfenac ophthalmic solution) 0.07 percent prescription eye drop, an innovative once-daily nonsteroidal anti-inflammatory drug for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.

9 Apr 2013

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration for the execution of arcuate incisions during cataract surgery.

3 Apr 2013

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Recent study findings indicate that eyes with multifocal intraocular lenses implanted during cataract surgery may develop reduced visual sensitivity.

8 Mar 2013

Avedro announces completion of $43M Series D financing

Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point.

5 Mar 2013

Discovery about eye’s shape could boost effectiveness of lenses used in cataract operations

A professor at London's Kingston University has made a discovery about the shape of the eye that could boost the effectiveness of man-made lenses used in cataract operations.

1 Mar 2013

Oraya Therapy safe and effective for patients with wet AMD

Oraya Therapeutics, Inc. today announced that one of the patients who successfully was treated for wet age-related macular degeneration (AMD) with Oraya Therapy during the INTREPID clinical trial has released data showing he has experienced significant, sustained vision improvement more than two years after treatment in his right eye, without any subsequent anti-vascular endothelial growth factor (anti-VEGF) injections or other treatment.

1 Mar 2013

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Clearview Eye & Laser Medical Center announces the arrival of the world's most sophisticated laser cataract surgery system in Southern CA.

24 Feb 2013

Pediatric blindness etiology varies around the globe

The causes and prevalence of blindness in children vary markedly by geography, presumably as a proxy for socioeconomic factors influencing prevention and treatment schemes, conclude the authors of a literature review.

15 Feb 2013

National Eye Institute’s booklet and videos help people adapt to life with low vision

A 20-page large-print booklet and a series of videos to help people adapt to life with low vision are available from the National Eye Institute (NEI), a part of the National Institutes of Health. The materials were released during Low Vision Awareness Month, February 2013.

2 Feb 2013

Congenital sight impairment cure grows closer

A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.

31 Jan 2013

Study explores regular aspirin use and potential risks for macular degeneration

This week, a study published in the journal JAMA Internal Medicine, explored the connection between regular aspirin use and the potential risks for developing the blinding eye disease, macular degeneration. As a result, there is increased confusion and anxiety in the general public about whether aspirin can harm your vision and what to do if you need the heart-protective therapy.

28 Jan 2013

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.

18 Jan 2013

BubR1 and its associated regulators promising targets for aging disorders and cancer

A new series of studies in mouse models by Mayo Clinic researchers uncovered that the aging process is characterized by high rates of whole-chromosome losses and gains in various organs, including heart, muscle, kidney and eye, and demonstrate that reducing these rates slows age-related tissue deterioration and promotes a healthier life span. The findings appear in today's online issue of Nature Cell Biology.

18 Dec 2012

$Study finds increase in prevalence of nonrefractive visual impairment in the U.S.$

Study finds increase in prevalence of nonrefractive visual impairment in the U.S.

The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.

12 Dec 2012

FDA clearance for LENSAR Laser System

LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.

10 Dec 2012

Bayer submits MAA in Europe for EYLEA to treat macular edema after CRVO

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for EYLEA (aflibercept) Injection for the treatment of macular edema following Central Retinal Vein Occlusion (CRVO).

6 Dec 2012

Cataract News and Research

Latest Cataract News and Research

First Edition: May 21, 2013

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Sony Electronics installs medical-grade 3D imaging solution for ophthalmic surgery

FDA approves PROLENSA for treatment of inflammation, pain after cataract surgery

FDA clears LENSAR Laser System to perform corneal, arcuate incisions during cataract surgery

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Avedro announces completion of $43M Series D financing

Discovery about eye’s shape could boost effectiveness of lenses used in cataract operations

Oraya Therapy safe and effective for patients with wet AMD

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Pediatric blindness etiology varies around the globe

National Eye Institute’s booklet and videos help people adapt to life with low vision

Congenital sight impairment cure grows closer

Study explores regular aspirin use and potential risks for macular degeneration

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

BubR1 and its associated regulators promising targets for aging disorders and cancer

Study finds increase in prevalence of nonrefractive visual impairment in the U.S.

FDA clearance for LENSAR Laser System

Bayer submits MAA in Europe for EYLEA to treat macular edema after CRVO

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cataract News and Research

Latest Cataract News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in